144 related articles for article (PubMed ID: 28466570)
1. Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases.
Boyle T; Connors JM; Gascoyne RD; Berry BR; Sehn LH; Bashash M; Spinelli JJ
Br J Haematol; 2017 Aug; 178(3):442-447. PubMed ID: 28466570
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
4. Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma.
Magnano L; Balagué O; Dlouhy I; Rovira J; Karube K; Pinyol M; Rivas-Delgado A; Costa D; Martínez-Trillos A; González-Farre B; Martínez-Pozo A; Giné E; Colomer D; Delgado J; Villamor N; Campo E; López-Guillermo A
Ann Oncol; 2017 Nov; 28(11):2799-2805. PubMed ID: 29045517
[TBL] [Abstract][Full Text] [Related]
5. Presence of autoimmune disease affects not only risk but also survival in patients with B-cell non-Hodgkin lymphoma.
Kleinstern G; Averbuch M; Abu Seir R; Perlman R; Ben Yehuda D; Paltiel O
Hematol Oncol; 2018 Apr; 36(2):457-462. PubMed ID: 29469175
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and outcomes in patients receiving chemotherapy for intermediate-grade B-cell non-Hodgkin lymphoma.
Jones JA; Fayad LE; Elting LS; Rodriguez MA
Leuk Lymphoma; 2010 Sep; 51(9):1649-57. PubMed ID: 20807093
[TBL] [Abstract][Full Text] [Related]
7. Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study.
Keegan TH; Moy LM; Foran JM; Alizadeh AA; Chang ET; Shema SJ; Schupp CW; Clarke CA; Glaser SL
Leuk Lymphoma; 2013 Apr; 54(4):743-51. PubMed ID: 22957852
[TBL] [Abstract][Full Text] [Related]
8. Beyond the International Prognostic Index: new prognostic factors in follicular lymphoma and diffuse large-cell lymphoma A meeting report of the Second International Lunenburg Lymphoma Workshop.
Kersten MJ; Jong Dd Dd; Raemaekers JM; Kluin PM; Hagenbeek A
Hematol J; 2004; 5(3):202-8. PubMed ID: 15167905
[No Abstract] [Full Text] [Related]
9. Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group.
Provencio M; Royuela A; Torrente M; Pollán M; Gómez-Codina J; Sabín P; Llanos M; Gumá J; Quero C; Blasco A; Aguiar D; García-Arroyo FR; Lavernia J; Martínez N; Morales M; Saenz-Cusi Á; Rodríguez D; Calvo V; de la Cruz-Merino L; de la Cruz MÁ; Rueda A;
Cancer; 2017 Oct; 123(19):3709-3716. PubMed ID: 28608996
[TBL] [Abstract][Full Text] [Related]
10. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
11. Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma.
Carson KR; Bartlett NL; McDonald JR; Luo S; Zeringue A; Liu J; Fu Q; Chang SH; Colditz GA
J Clin Oncol; 2012 Sep; 30(26):3217-22. PubMed ID: 22649138
[TBL] [Abstract][Full Text] [Related]
12. Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis.
Lerch K; Meyer AH; Stroux A; Hirt C; Keller U; Viardot A; Marks R; Schreiber S; Pezzutto A; Scholz CW
Ann Hematol; 2015 Jun; 94(6):981-8. PubMed ID: 25645656
[TBL] [Abstract][Full Text] [Related]
13. [Comparison between CHOP-like and R-CHOP in diffuse large B cell and follicular lymphoma].
Oliver C; Guillermo C; Martínez P; Díaz L
Rev Med Chil; 2013 Jul; 141(7):844-52. PubMed ID: 24356732
[TBL] [Abstract][Full Text] [Related]
14. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
Maeshima AM; Taniguchi H; Fukuhara S; Morikawa N; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
[TBL] [Abstract][Full Text] [Related]
15. Obesity and risk of non-Hodgkin lymphoma (United States).
Chiu BC; Soni L; Gapstur SM; Fought AJ; Evens AM; Weisenburger DD
Cancer Causes Control; 2007 Aug; 18(6):677-85. PubMed ID: 17484069
[TBL] [Abstract][Full Text] [Related]
16. HIV Infection and Survival of Lymphoma Patients in the Era of Highly Active Antiretroviral Therapy.
Han X; Jemal A; Hulland E; Simard EP; Nastoupil L; Ward E; Flowers CR
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):303-311. PubMed ID: 27756777
[No Abstract] [Full Text] [Related]
17. Incidence, risk factors and outcome of histological transformation in follicular lymphoma.
Conconi A; Ponzio C; Lobetti-Bodoni C; Motta M; Rancoita PM; Stathis A; Moccia AA; Mazzucchelli L; Bertoni F; Ghielmini M; Cavalli F; Zucca E
Br J Haematol; 2012 Apr; 157(2):188-96. PubMed ID: 22348437
[TBL] [Abstract][Full Text] [Related]
18. Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas.
Lin TL; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Tang TC; Chang H; Hung YS; Lu SC
Ann Hematol; 2012 Nov; 91(11):1741-5. PubMed ID: 22729139
[TBL] [Abstract][Full Text] [Related]
19. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
[TBL] [Abstract][Full Text] [Related]
20. Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
Kridel R; Telio D; Villa D; Sehn LH; Gerrie AS; Shenkier T; Klasa R; Slack GW; Tan K; Gascoyne RD; Connors JM; Savage KJ
Br J Haematol; 2017 Jan; 176(2):210-221. PubMed ID: 27739058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]